0 NASDAQ Companies - March 28, 2019Molecular Templates Announces Initiation of Phase II Monotherapy Study of MT-3724 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma PatientsRead More
0 NASDAQ Companies - March 28, 2019Rubius Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results with Business UpdatesRead More
0 NASDAQ Companies - March 28, 2019Scale Space Applications with COTS-to-Radiation-Tolerant and Radiation-Hardened Arm® Core MCUsRead More
0 NASDAQ Companies - March 28, 2019China Recycling Energy Corp. Announces the Agreement of Intent with Qingzhou Taihuacheng to Build the Energy Storage Power StationRead More
0 NASDAQ Companies - March 28, 2019Agile Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference in London, UKRead More
0 NASDAQ Companies - March 28, 2019Marty Caywood Appointed Executive Vice President, Chief Information OfficerRead More
0 NASDAQ Companies - March 28, 2019Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteriovenous FistulasRead More
0 NASDAQ Companies - March 28, 2019Paratek Pharmaceuticals to Present at the 2019 H.C Wainwright Global Life Sciences ConferenceRead More
